Recently, protein tyrosine phosphatase 1B (PTP1B), a classical non-transmembrane tyrosine phosphatase, is emerging as a critical regulator in type 2 diabetes, obesity, and liver diseases, suggesting a promising therapeutic target in metabolic disorders 36. This evidence concerns the gene PTPN1 and type 2 diabetes mellitus.